As optimizations to linker and conjugation chemistries have become the single-biggest area of investment within the ADC field, the need for service providers with unique conjugation platforms and stable linkers is only increasing.
The inaugural ADC Linker & Conjugation Summit will unite key decision makers in the ADC community from large pharma and biotech such as Seagen, Genentech, Bolt Biotherapeutics, and more to address the challenges surrounding linker and conjugation chemistry including stability, targeted delivery and off-target toxicity.
With an audience ranging from senior decision-makers to chemists responsible for designing and assessing different linkers and conjugation technologies, this is your opportunity to get face-to-face with those directly working with your technology day in and day out.
How Can We Help You Win New Business?
We understand each business is different, so we will work with you to build a bespoke package to fulfill your business objectives by:
- Deliver a presentation to the engaged audience in the dedicated session to showcase your company’s expertise
- Hold a lunch or drinks reception to bring your company into the spotlight and have the leading experts’ undivided attention
- Secure a booth to present your capabilities to therapeutic developers who are actively seeking new solutions to optimize drug development inefficiencies
- Make your brand known with bespoke branding opportunities
- Network one-to-one with stakeholders during our coordinated networking sessions to first-hand understand their requirements and present your solution
The requirement for linker and conjugation platform technology providers has never been more timely - can you help?
Get in touch today to learn about how we can build a bespoke partnership to support your commercial objectives within this space.